The 2 Magnificent Seven Stocks With the Most Upside Potential, According to Wall Street

Article highlights Microsoft and Nvidia as two of the most undervalued “Magnificent Seven” names, citing Wall Street upside of ~45% for Microsoft (avg $559.93 target vs ~$385) and ~43% for Nvidia (avg $301.62 target vs current levels). Microsoft’s AI business exceeded a $37B annual run rate in FY2026 Q3 (+123% YoY), with Azure revenue up 40% YoY and a $627B cloud backlog (+99% YoY), while Nvidia expects ~$20B in stand-alone CPU revenue by year-end and a ~$200B addressable market, alongside continued GPU demand tied to rising AI infrastructure capex (Alphabet capex guidance $180B–$190B this year; up in 2027). Overall, the tone is constructive on long-run AI/cloud tailwinds despite some investor skepticism about valuation and competitive pressures.

Analysis

The incremental read-through is not “AI is working,” but that the capex cycle is becoming self-reinforcing: when hyperscalers keep raising infrastructure budgets, the spend migrates from optional experimentation to a must-have operating expense. That favors NVDA first because it remains the toll collector on accelerated compute, while MSFT benefits more defensively through attach, pricing power, and embedded workflow control. The second-order loser is any software vendor selling generic productivity tools without distribution or data advantage; the AI narrative can compress their multiples even if fundamentals have not yet broken.

The market is probably still underestimating how much of the near-term upside is already in consensus. MSFT’s upside case depends on continued monetization converting capex into FCF, not just narrative momentum; if Azure growth decelerates materially over the next 1-2 quarters, the stock can de-rate despite strong absolute numbers. For NVDA, the bigger risk is not “custom silicon kills the franchise” in the next few months, but that custom chips and inference optimization cap the multiple if revenue growth stays high but becomes less scarce.

Contrarian view: the crowd is focusing on TAM and missing duration risk. A lot of AI spend is being funded by large, visible players, which makes the trade powerful now but also easier to fade if one or two buyers slow spending or shift mix toward in-house ASICs. The falsifier is straightforward: if hyperscaler capex guidance rolls over or AI monetization stops accelerating into the next earnings season, both names can underperform even in a healthy tape. Near term, this is more a momentum/quality factor than a pure fundamental re-rating story.

Key Decisions for Investors

• Stay constructive but patient on NVDA: add on 5-8% pullbacks rather than chasing strength; risk/reward is best if hyperscaler capex remains upwardly revised into the next 1-2 quarters.
• For MSFT, prefer a staggered entry or call-spread structure over outright size; the stock can work over 6-18 months, but near-term multiple expansion looks capped unless Azure and AI monetization reaccelerate together.
• Pair-trade idea: long NVDA / short a software basket proxy (e.g., IGV or an equivalent weakest AI-disruption beneficiary) to express the view that infrastructure monetization outperforms application-layer enthusiasm over the next 3-6 months.
• Set a catalyst alert on the next hyperscaler capex guide and Azure growth print: if either decelerates sharply, cut bullish exposure because the market will likely de-rate both MSFT and NVDA within days.
• If NVDA trades at a premium that implies perfection, consider replacing part of the common with call spreads into earnings to reduce downside from any guidance asymmetry.